| Patents for C07D 471 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups (64,559) |
|---|
| 01/04/2007 | US20070004710 6-({2-[4-(6-Methoxy-[1,5]naphthyridin-4-yl)phenyl]ethylamino}methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one;bacterial infections; antibiotic resistance; Staphylococcus aureus, Streptococcus pneumoniae and pyogenes, Enterococcus; Haemophilus influenzae, Moraxella catarrhalis, E-coli |
| 01/04/2007 | US20070004708 1-{1-[1-(4-Methoxy-2-methylphenyl)-6-methyl-2,3-dihydro-1H-pyrrolo[2,3-b]pyridin-4-yl]-1H-pyrazol-3-yl}imidazolidin-2-one; potent; to treat central nervous system disorders; antidepressants; Anxiolytic agents; mood disorders; anagesics; gastrointestinal disorders like irritable bowel syndrome |
| 01/04/2007 | US20070004707 5HT2c agonists or partial agonists; e.g., 4,5,6,7,9a,10,11,12,13,13a-decahydro-9H-(1,4)diazepino-(6,7,1 -de)phenanthridine hydrochloride; schizophrenia, Parkinson's disease, psychosis associated with Lewy body disease, dementia, memory deficit; psychosis |
| 01/04/2007 | US20070004695 Thienoisoxazolyl-and thienylpyrrazolyl phenoxy substituted propyl derivatives useful as d4 antagonists |
| 01/04/2007 | US20070004684 Alpha-Carbolines as CDK-1 inhibitors |
| 01/04/2007 | US20070003788 Organic electroluminescence device |
| 01/04/2007 | CA2613090A1 Foaming agents and compositions containing fluorine substituted olefins, and methods of foaming |
| 01/04/2007 | CA2612986A1 Compositions containing fluorine substituted olefins |
| 01/04/2007 | CA2612969A1 Oxazolidinone derivatives and use thereof as antibiotics |
| 01/04/2007 | CA2612585A1 Anti-inflammatory aryl nitrile compounds |
| 01/04/2007 | CA2612554A1 Non-nucleoside reverse transcriptase inhibitors |
| 01/04/2007 | CA2612300A1 Pyrazolo[3,4-b]pyridin-2-yl]-benzoic acid derivatives as hiv integrase inhibitors |
| 01/04/2007 | CA2611296A1 Pyrazolopyridine derivatives as inhibitors of beta-adrenergic receptor kinase 1 |
| 01/04/2007 | CA2610959A1 Piperidine derivatives useful as histamine h3 antagonists |
| 01/04/2007 | CA2582233A1 Process for preparing 4,5-dihydro-pyrazolo [3,4-c] pyrid-2-ones |
| 01/03/2007 | EP1739087A1 Pyrazole compositions useful as inhibitors of gsk-3 |
| 01/03/2007 | EP1739082A1 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis |
| 01/03/2007 | EP1737865A1 Fused derivatives of pyrazole |
| 01/03/2007 | EP1737864A1 Selected cgrp antagonists, methods for the production thereof, and use thereof as medicaments |
| 01/03/2007 | EP1737863A2 2-cyanopyrrolidinecarboxamides as dipeptidyl peptidase-iv inhibitors |
| 01/03/2007 | EP1737862A1 Imidazopyridine compound |
| 01/03/2007 | EP1737860A1 Selected cgrp-antagonists, their preparation processes and their use as medicaments |
| 01/03/2007 | EP1737859A1 Novel crystalline form of 8-cyano-1-cyclopropyl-7-(1s,6s-2,8-diazabicyclo¬4.3.0|nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinoline carboxylic acid |
| 01/03/2007 | EP1737858A1 Sulfonamides |
| 01/03/2007 | EP1737857A1 Pyrazolo[3,4-b] pyridine compounds, and their use as phosphodiesterase inhibitors |
| 01/03/2007 | EP1737852A2 Polycyclic pyridines as potassium ion channel modulators |
| 01/03/2007 | EP1737842A1 Selected cgrp antagonists, method for producing the same and the use thereof as drugs |
| 01/03/2007 | EP1737831A1 Neurologically-active compounds |
| 01/03/2007 | EP1737824A2 Novel alkyne compounds having an mch-antagonistic effect, and medicaments containing said compounds |
| 01/03/2007 | EP1737813A1 Androgen modulators |
| 01/03/2007 | EP1737461A1 Carboline derivatives useful in the inhibition of angiogenesis |
| 01/03/2007 | EP1737459A1 Imidazopyridine and imidazopyrimidine derivatives as antibacterial agents |
| 01/03/2007 | EP1737297A2 Imidazole compounds |
| 01/03/2007 | EP1562925B1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/03/2007 | EP1280798B1 Bicyclic heterocylces, medicaments containing said compounds, the use thereof and method for producing them |
| 01/03/2007 | CN1890240A Diazabicyclononene derivatives and their use as renin inhibitors |
| 01/03/2007 | CN1890239A Azabicyclooctene and other tetrahydropyridine derivatives with a new side-chain |
| 01/03/2007 | CN1890238A Hydronopol derivatives as agonists on human ORL1 receptors |
| 01/03/2007 | CN1890234A Novel quinoline derivatives |
| 01/03/2007 | CN1890223A Capsaicin receptor agonists |
| 01/03/2007 | CN1887884A Quinolyl dione derivative and its application in preparing antibiotic medicine |
| 01/03/2007 | CN1887877A Thirteen-eliment nanometer RE anticancer compound and its prepn and application |
| 01/03/2007 | CN1887876A Nanometer RE heterocyclic anticancer compound and its prepn and application |
| 01/03/2007 | CN1293078C Imidazo fused compounds |
| 01/03/2007 | CN1293063C Substituted heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 01/03/2007 | CN1293057C Ethylenediamine derivatives |
| 01/03/2007 | CN1293042C Aromatic amino acid derivates and medicinal compositions |
| 01/03/2007 | CN1293040C Process for the preparation of phenylalanine enamide derivatives |
| 01/02/2007 | US7157575 Measuring gene expression |
| 01/02/2007 | US7157490 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 01/02/2007 | US7157488 N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine; treating schizophrenia, anxiety, Alzheimer's disease, and cognitive disorders |
| 01/02/2007 | US7157487 Vla-4 inhibitors |
| 01/02/2007 | US7157486 For therapy and prophylaxis of hepatitis C virus (HCV) infection |
| 01/02/2007 | US7157468 Pyrazole derivatives |
| 01/02/2007 | US7157466 Quinazoline ditosylate salt compounds |
| 01/02/2007 | US7157460 Use of 8-amino-aryl-substituted imidazopyrazines as kinase inhibitors |
| 01/02/2007 | US7157457 Compounds useful in the treatment of inflammatory diseases |
| 01/02/2007 | US7157453 Urea substituted imidazoquinolines |
| 01/02/2007 | US7157196 Naphthalenetetracarboxylic acid diimide derivatives and electrophotographic photoconductive material having the same |
| 01/02/2007 | CA2365495C Viral treatment |
| 01/02/2007 | CA2236691C Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters |
| 12/28/2006 | WO2006138695A1 Triazolopyridine derivatives as cannabinoid receptor 1 antagonists |
| 12/28/2006 | WO2006138657A1 Bicyclic heterocycles as cannabinoid-1 receptor modulators |
| 12/28/2006 | WO2006138604A1 Hexahydro-pyrrolo-isoquinoline compounds for the treatment of cns disorders |
| 12/28/2006 | WO2006138217A1 Aspartyl protease inhibitors |
| 12/28/2006 | WO2006137791A1 New azetidine derivatives as neurokinin receptor antagonists for the treatment of gastrointestinal diseases |
| 12/28/2006 | WO2006137527A1 Thiazole derivative |
| 12/28/2006 | WO2006136859A2 Indoli zine derivatives and their use as crth2 antagonists |
| 12/28/2006 | WO2006136561A1 1- ( 2-amino-3- (substituted alkyl)-3h-benzimidazoiylmethyl) -3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| 12/28/2006 | WO2006136442A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/28/2006 | WO2006135993A1 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c. |
| 12/28/2006 | WO2006092032B1 PHARMACEUTICAL COMPOSITIONS CONTAINING 1-METHYL-3,6,7,8-TETRAHYDROPIRAZOLO[3,4-b]PIRROLO[4,3-d]PYRIDINE-6,8-DIONE DERIVATIVES, USE, AND PROCESS FOR PREPARING THEM |
| 12/28/2006 | WO2006056873A3 Therapeutic pyrazolo[3,4-b] pyridines and indazoles |
| 12/28/2006 | WO2006009789A3 Aryl-substituted piperazine derivatives |
| 12/28/2006 | US20060293371 Prodrug and process for producing the same |
| 12/28/2006 | US20060293348 CSBP/p38 kinase inhibitor; antiinflammatory agent; inflammatory bowel disease; tuberculosis, atherosclerosis, muscle degeneration, cachexia, psoriatic arthritis, rheumatoid arthritis; 8-(2,4,6-trifluorophenyl)-4-(2,4-difluorophenyl)-2-(2-hydroxy-1-hydroxymethylethylamino)-8H-pyridio[2,3]pyrimidin-7-one |
| 12/28/2006 | US20060293344 Viricide against herpes virus; a pyrazolo[1,5- alpha]pyridinyl compounds; chemical synthesis |
| 12/28/2006 | US20060293338 protein serine/threonine kinase inhibitors such as 2-(2-Chloro-5-fluoro-phenylimino)-5-(2,3-dihydro-benzo[1-6]dioxin-6-ylmethylene)-thiazolidin-4-one, used for treating autoimmune diseases, HIV, cancer, anemia myelodysplastic syndrome and thrombocytopenia |
| 12/28/2006 | US20060293335 Riboflavin derivative and its manufacture and uses |
| 12/28/2006 | US20060293334 Nitrogen-containing heteroaryl compounds having inhibitory activity against HIV integrase |
| 12/28/2006 | US20060293316 such as Cis-6-Phenyl-9-(3-piperidin-1-yl-propoxy)-1,2,3,5,6,10b-hexahydro-pyrrolo [2,1a]isoquinoline, used as histamine H3 receptor and serotonin transporter modulators useful in the treatment of depression |
| 12/28/2006 | US20060293306 1-Cyclopentyl-3-methyl-2-(2-pyridyl)indole-5-thio/carbonyl derivatives; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons |
| 12/28/2006 | US20060293304 Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein |
| 12/28/2006 | US20060293303 e.g. 2-(4-Fluorophenyl)-7-(1-methylpiperidin-4-yl)-3-(2-methylpyrimidin-4-yl)imidazo[1,2-a]-pyridine; protozoal diseases (toxoplasmosis, malaria, African typanosomiasis, Chagas disease, and opportunistic infections) in mammals and birds; controlling coccidiosis in poultry |
| 12/28/2006 | US20060293302 For therapy of acute inflammatory diseases: Septic shock, sepsis, SIRS, hemorrhagic shock, shock states induced by cytokine therapy (IL-2, TNF), organ transplantation and transplant rejection, head trauma, acute lung injury, ARDS, inflammatory skin conditions such as sunburn, inflammatory eye conditions |
| 12/28/2006 | DE102005027619A1 Verfahren zur Herstellung von 3,7-Diaza-bicyclo[3.3.1]nonan-Verbindungen Process for the preparation of 3,7-diaza-bicyclo [3.3.1] nonane compounds |
| 12/28/2006 | CA2612788A1 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for treating hepatitis c |
| 12/28/2006 | CA2612495A1 Hexahydro-pyrrolo-isoquinoline compounds for the treatment of cns disorders |
| 12/28/2006 | CA2612409A1 Naphthyridine compounds |
| 12/28/2006 | CA2612263A1 1-(2-amino-3-(substituted alkyl)-3h-benzimidazolylmethyl)-3-subtituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus |
| 12/28/2006 | CA2610815A1 Aspartyl protease inhibitors |
| 12/28/2006 | CA2610742A1 Pyrimidine derivatives for the treatment op gaba b mediated nervous system disorders |
| 12/28/2006 | CA2598216A1 Androgen receptor modulator compounds and methods |
| 12/27/2006 | EP1736468A2 Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation |
| 12/27/2006 | EP1736465A1 Aniline derivatives |
| 12/27/2006 | EP1736155A1 Medicine comprising combination of acetylcholine esterase inhibitor and 5-substituted 3-oxadiazolyl-1,6-naphthyridin-2(1h)-one derivative |
| 12/27/2006 | EP1735320A1 Compounds and methods for treating dyslipidemia |
| 12/27/2006 | EP1735319A1 Inhibitors of histone deacetylase |
| 12/27/2006 | EP1735315A1 PYRAZOLO[3,4-b]PYRIDINE COMPOUNDS, AND THEIR USE AS PDE4 INHIBITORS |
| 12/27/2006 | EP1735313A1 Substituted diaza-spiro-[4.5|-decane derivatives and their use as neurokinin antagonists |